5 Stocks Under $10 Poised to Move Higher
Repligen
One under-$10 stock that's just starting to trigger a big breakout trade is Repligen (RGEN), a biopharmaceutical company focused on the development and commercialization of therapies that harness biological pathways and deliver value to patients and clinicians in the fields of neurology and gastroenterology. This stock is off to a monster start in 2012 with shares up over 42%.
If you take a look at the chart for Repligen, you'll see that this stock has been uptrending very strong for the past four months. This strong uptrend started right after the stock broke out above some past overhead resistance at $3.58 to $3.72 a share on monster volume. Following that breakout, the stock soared towards its current price of just under $5 a share. This strong move has now pushed RGEN within range of triggering another major breakout.
Market players should now watch RGEN for a breakout trade if this stock can manage to take out some near-term overhead resistance at $4.92 to $5.12 with high volume. A sustained high-volume move and close over those levels should set this stock up to re-test its next significant overhead resistance level at $5.36 a share. Look for volume on a move above $4.92 to $5.36 that registers near or well above its three-month average action of 43,237 shares. If we get that action soon, then RGEN has a great chance to trend higher toward $6 to $7 a share in the very near future.
I would consider looking for long-biased trades in RGEN as long as it's trending above $4.92 to $5.36 a share with strong upside volume flows. I would simply avoid this stock from the long side if it fails to trend above those levels and drops back below some near-term support at $4.65 with volume. Follow @stockpickrSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV